Tirbanibulin Suppliers & Bulk Manufacturers
Available Forms: Ointment
Available Strengths: 1%
Reference Brands: Klisyri (USA)
Category: Derma Drugs
Tirbanibulin is a microtubule inhibitor that binds to tubulin and inhibits tubulin polymerization. It also inhibits Src‑kinase signalling pathways. By doing so, it arrests cell division in rapidly dividing skin cells affected by sun damage, leading to their death. It is used for the topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis on the face or scalp, helping clear precancerous skin lesions and reduce the risk of progression. Tirbanibulin is available in Ointment and strengths such as 1%. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tirbanibulin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tirbanibulin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tirbanibulin is used to treat actinic keratosis, a precancerous skin condition caused by sun damage. It works by inhibiting tubulin polymerization and Src kinase signaling, which disrupts the growth of abnormal skin cells.
Tirbanibulin is made from the active pharmaceutical ingredient tirbanibulin, a synthetic molecule that targets cellular microtubules and signaling pathways involved in abnormal cell proliferation.
The trade name is Klisyri.
Klisyri is manufactured by Almirall, S.A.
The generic name is tirbanibulin.
The primary brand name is Klisyri.
It is manufactured in approved pharmaceutical facilities in Europe and other regions depending on regulatory approvals.
Related Products
Acitretin
Strength:
10 mg, 17.5 mg, 22.5 mg, 25 mg
Form: Capsules
Reference Brands: Soriatane (USA), Neotigason (EU)
View Details
Mafenide
Strength:
10% w/w
Form: Creams
Reference Brands: Sulfamylon(USA), Flamazine (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
